Phloretin (Synonyms: NSC 407292, RJC 02792) |
|
Catalog No.GC17976
|
Phloretin is a dihydrochalcone flavonoid that inhibits yeast-derived GLUT1 and erythrocyte GLUT1 with IC50 values of 49μM and 61μM, respectively.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 60-82-2
Sample solution is provided at 25 µL, 10mM.
Phloretin is a dihydrochalcone flavonoid that inhibits yeast-derived GLUT1 and erythrocyte GLUT1 with IC50 values of 49μM and 61μM, respectively[1]. Phloretin displays potent antioxidant activity in peroxynitrite scavenging and the inhibition of lipid peroxidation, modulates Ca2+ levels and down-regulates the secretion of IL-2 of normal human lymphocytes, and counteracts advanced glycation end product formation[2]. Phloretin can penetrate the skin and has been widely used in dermatological research to prevent excessive skin pigmentation and skin damage[3].
In vitro, Phloretin treatment for 48 hours significantly inhibited the viability of HCT-116, SW-480, and IEC-6 cells, with IC50 values of 152.43µM, 127.50µM, and 412.56µM, respectively[4]. Treatment with 200µM Phloretin for 48 hours induced morphological changes in U87 and U251 cells, caused cell cycle arrest and accumulation of reactive oxygen species (ROS), inhibited the PI3K/Akt/mTOR signaling pathway, and increased the expression of PTEN[5]. Treatment with 75µg/ml Phloretin for 24 hours elicited apoptosis in A549 and Calu-1 cells, enhanced the expression of cleaved-caspase-3 and caspase-9, and decreased the levels of MMP-2 and MMP-9[6].
In vivo, Phloretin treatment via intraperitoneal injection at a dose of 20mg/kg, twice a week for 12 weeks, reduced the body weight and fat weight of obese mice on a high-fat diet (HFD), and alleviated hepatocyte steatosis[7]. Daily intraperitoneal injection of Phloretin (20mg/kg/day) for 7 days alleviated acute lung injury induced by lipopolysaccharide (LPS) in mice, inhibited neutrophil infiltration into lung tissue, and reduced the levels of IL-6 and TNF-α in serum and bronchoalveolar lavage fluid[8].
References:
[1] KASAHARA T, KASAHARA M. Expression of the rat GLUT1 glucose transporter in the yeast Saccharomyces cerevisiae[J]. Biochemical Journal, 1996, 315(1): 177-182.
[2] Behzad S, Sureda A, Barreca D, et al. Health effects of phloretin: from chemistry to medicine[J]. Phytochemistry reviews, 2017, 16(3): 527-533.
[3] Casarini T P A, Frank L A, Pohlmann A R, et al. Dermatological applications of the flavonoid phloretin[J]. European Journal of Pharmacology, 2020, 889: 173593.
[4] Kapoor S, Padwad Y S. Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells[J]. Apoptosis, 2023, 28(5): 810-829.
[5] Liu Y, Fan C, Pu L, et al. Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species[J]. Journal of Neuro-oncology, 2016, 128(2): 217-223.
[6] Ma L, Wang R, Nan Y, et al. Phloretin exhibits an anticancer effect and enhances the anticancer ability of cisplatin on non-small cell lung cancer cell lines by regulating expression of apoptotic pathways and matrix metalloproteinases[J]. International Journal of Oncology, 2015, 48(2): 843-853.
[7] Liou C J, Wu S J, Shen S C, et al. Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice[J]. Cell & Bioscience, 2020, 10(1): 114.
[8] Huang W C, Lai C L, Liang Y T, et al. Phloretin attenuates LPS-induced acute lung injury in mice via modulation of the NF-κB and MAPK pathways[J]. International immunopharmacology, 2016, 40: 98-105.
| Cell experiment [1]: | |
|
Cell lines |
SW-480 cells |
|
Preparation Method |
SW-480 cells were cultured in Leibovitz’s L-15 medium, supplemented with 10% fetal bovine serum (FBS) and 1% antibiotic–antimycotic, at 37°C in an incubator with 5% CO2. Cells were inoculated at 4000 cells/well into 96-well plates and treated with Phloretin at various concentrations (10, 25, 50 100, 200, and 300µM) for 48h, the cell proliferation was tested. |
|
Reaction Conditions |
10, 25, 50 100, 200, and 300µM; 48h |
|
Applications |
Phloretin treatment reduced cell proliferation of SW-480 cells in a dose-dependent manner. |
| Animal experiment [2]: | |
|
Animal models |
C57BL/6 mice |
|
Preparation Method |
C57BL/6 mice (4 weeks old) were randomly divided into 3 groups of 10. HFD based on research diets containing 23.1% protein, 34.9% fat, and 25.8% carbohydrates, and fat supplying 60% of energy. The normal control group (N) and HFD control group (HFD) were fed a standard chow diet or HFD, respectively, and administered DMSO solution by intraperitoneal injection. Phloretin groups were fed a HFD and administered 20mg/kg Phloretin by intraperitoneal injection (twice a week) for 12 weeks. Liver tissues from mice were collected for analysis. |
|
Dosage form |
20mg/kg; twice a week; 12 weeks; i.p. |
|
Applications |
Phloretin treatment suppressed liver lipid accumulation and improved hepatocyte steatosis in mice with HFD. |
References: [1] Kapoor S, Padwad Y S. Phloretin induces G2/M arrest and apoptosis by suppressing the β-catenin signaling pathway in colorectal carcinoma cells[J]. Apoptosis, 2023, 28(5): 810-829. [2] Liou C J, Wu S J, Shen S C, et al. Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice[J]. Cell & Bioscience, 2020, 10(1): 114. | |
| Cas No. | 60-82-2 | SDF | |
| Synonyms | NSC 407292, RJC 02792 | ||
| Chemical Name | 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one | ||
| Canonical SMILES | O=C(C1=C(O)C=C(O)C=C1O)CCC2=CC=C(O)C=C2 | ||
| Formula | C15H14O5 | M.Wt | 274.27 |
| Solubility | ≥ 105 mg/mL in DMSO, ≥ 87.6 mg/mL in EtOH | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 3.646 mL | 18.2302 mL | 36.4604 mL |
| 5 mM | 729.2 μL | 3.646 mL | 7.2921 mL |
| 10 mM | 364.6 μL | 1.823 mL | 3.646 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL saline, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Quality Control & SDS
- View current batch:
- Purity: >98.50% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)















